Literature DB >> 21660504

Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments.

Kayode Ogungbenro1, Leon Aarons.   

Abstract

In the recent years, interest in the application of experimental design theory to population pharmacokinetic (PK) and pharmacodynamic (PD) experiments has increased. The aim is to improve the efficiency and the precision with which parameters are estimated during data analysis and sometimes to increase the power and reduce the sample size required for hypothesis testing. The population Fisher information matrix (PFIM) has been described for uniresponse and multiresponse population PK experiments for design evaluation and optimisation. Despite these developments and availability of tools for optimal design of population PK and PD experiments much of the effort has been focused on repeated continuous variable measurements with less work being done on repeated discrete type measurements. Discrete data arise mainly in PDs e.g. ordinal, nominal, dichotomous or count measurements. This paper implements expressions for the PFIM for repeated ordinal, dichotomous and count measurements based on analysis by a mixed-effects modelling technique. Three simulation studies were used to investigate the performance of the expressions. Example 1 is based on repeated dichotomous measurements, Example 2 is based on repeated count measurements and Example 3 is based on repeated ordinal measurements. Data simulated in MATLAB were analysed using NONMEM (Laplace method) and the glmmML package in R (Laplace and adaptive Gauss-Hermite quadrature methods). The results obtained for Examples 1 and 2 showed good agreement between the relative standard errors obtained using the PFIM and simulations. The results obtained for Example 3 showed the importance of sampling at the most informative time points. Implementation of these expressions will provide the opportunity for efficient design of population PD experiments that involve discrete type data through design evaluation and optimisation.

Entities:  

Mesh:

Year:  2011        PMID: 21660504     DOI: 10.1007/s10928-011-9203-7

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  31 in total

1.  POPED, a software for optimal experiment design in population kinetics.

Authors:  Marco Foracchia; Andrew Hooker; Paolo Vicini; Alfredo Ruggeri
Journal:  Comput Methods Programs Biomed       Date:  2004-04       Impact factor: 5.428

2.  The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments.

Authors:  Kayode Ogungbenro; Gordon Graham; Ivelina Gueorguieva; Leon Aarons
Journal:  Comput Methods Programs Biomed       Date:  2005-08-31       Impact factor: 5.428

3.  Optimal design for multivariate response pharmacokinetic models.

Authors:  Ivelina Gueorguieva; Leon Aarons; Kayode Ogungbenro; Karin M Jorga; Trudy Rodgers; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-03-21       Impact factor: 2.745

4.  Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic experiments.

Authors:  Kayode Ogungbenro; Gordon Graham; Ivelina Gueorguieva; Leon Aarons
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

5.  Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

6.  Optimisation of sampling windows design for population pharmacokinetic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-09-09       Impact factor: 2.745

7.  Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

Authors:  B C Tilley; G S Alarcón; S P Heyse; D E Trentham; R Neuner; D A Kaplan; D O Clegg; J C Leisen; L Buckley; S M Cooper; H Duncan; S R Pillemer; M Tuttleman; S E Fowler
Journal:  Ann Intern Med       Date:  1995-01-15       Impact factor: 25.391

8.  An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Biopharm Stat       Date:  2009       Impact factor: 1.051

9.  Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experiments.

Authors:  Gordon Graham; Leon Aarons
Journal:  Stat Med       Date:  2006-12-15       Impact factor: 2.373

10.  Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designs.

Authors:  Kayode Ogungbenro; Ivelina Gueorguieva; Oneeb Majid; Gordon Graham; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-02-07       Impact factor: 2.410

View more
  5 in total

1.  Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments.

Authors:  Holger Dette; Andrey Pepelyshev; Weng Kee Wong
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-05-22       Impact factor: 2.745

2.  D optimal designs for three Poisson dose-response models.

Authors:  Alan Maloney; Ulrika S H Simonsson; Marloes Schaddelee
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-19       Impact factor: 2.745

3.  Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model.

Authors:  C Steven Ernest; Joakim Nyberg; Mats O Karlsson; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-12       Impact factor: 2.745

4.  Pharmacokinetic and pharmacodynamic analysis comparing diverse effects of detomidine, medetomidine, and dexmedetomidine in the horse: a population analysis.

Authors:  K N Grimsrud; S Ait-Oudhia; B P Durbin-Johnson; D M Rocke; K R Mama; M L Rezende; S D Stanley; W J Jusko
Journal:  J Vet Pharmacol Ther       Date:  2014-07-29       Impact factor: 1.786

5.  Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014).

Authors:  F T Musuamba; E Manolis; N Holford; Sya Cheung; L E Friberg; K Ogungbenro; M Posch; Jwt Yates; S Berry; N Thomas; S Corriol-Rohou; B Bornkamp; F Bretz; A C Hooker; P H Van der Graaf; J F Standing; J Hay; S Cole; V Gigante; K Karlsson; T Dumortier; N Benda; F Serone; S Das; A Brochot; F Ehmann; R Hemmings; I Skottheim Rusten
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.